Viewing nowMteranapin Tablets (Terbinafine Hydrochloride)
Terbinafine Hydrochloride 140.625mg
Tablet · Prescription medication
McNulty Pharmaceutical Co., Ltd.

MFDS item code 201603638 · Approved 2016.06.20 · Insurance code 641502210
Treatment of dermatophyte infections (athlete's foot, tinea corporis, etc.) and onychomycosis
This medication is used in adults for the treatment of dermatophyte infections such as athlete's foot, tinea corporis, tinea cruris, and onychomycosis, as well as tinea capitis in children.
As terbinafine, administer 125 mg once, twice a day, or 250 mg once a day. The duration of treatment varies based on the condition: 1) Dermatophytosis Athlete's foot (interdigital and plantar/moccasin type): 2-6 weeks Tinea corporis: 2-4 weeks Tinea cruris: 2-4 weeks 2) Onychomycosis Usually administered for 6 weeks to 3 months. If nails or relatively small toes are infected, or if the patient is very young, the treatment period may be reduced to less than 3 months. The generally sufficient duration for nail infections is usually 3 months, but some patients may require 6 months or more. For patients with slow nail growth, the treatment period may be extended. 2. Pediatric dosing: Administer to children over 2 years of age. There is no experience with children under 2, so it is not recommended for this age group. Tinea capitis: 4 weeks Tinea capitis mostly occurs in children. To prevent recurrence, treatment should be carried out consistently for an appropriately designated period. 1) For children under 20 kg (5 years and younger): 62.5 mg once daily. Due to insufficient experience, the decision to administer should consider the benefits and risks of treatment. 2) For children weighing 20-40 kg (5-12 years): 125 mg once daily. 3) For children over 40 kg (over 12 years): 250 mg once daily. 3. For patients with renal impairment For patients with a creatinine clearance of less than 50 mL/min, reduce the daily dose by 1/2.
Administer to children over 2 years of age. There is no experience with children under 2, so it is not recommended for this age group. Tinea capitis: 4 weeks 1) For children under 20 kg (under 5 years): 62.5 mg once
This medication is not recommended for patients with poor liver function. It is essential to check for liver disease before taking and to undergo regular liver function tests before and during treatment. If symptoms of liver dysfunction appear, discontinue use immediately and consult a physician. This drug should not be used in patients with certain blood disorders, severe kidney dysfunction, children under 2 years of age, and nursing women. Patients with genetic metabolic disorders such as lactose intolerance should also avoid this medication. Use caution in patients with compromised kidney function, elderly patients over 65, and underweight children. If severe skin rashes or allergic reactions occur, discontinue use immediately. This medication can cause various adverse reactions related to the liver, so frequent liver function tests and monitoring of symptoms are recommended from the start of treatment. Adverse effects can occur in various systems including blood, skin, muscles, digestive system, and nervous system, so if any unusual symptoms appear, notify a physician immediately. This medication may interact with other drugs, so if you are taking other medications, inform your physician or pharmacist, especially when using medications metabolized by the liver. Women who are pregnant or may become pregnant should use this medication with caution, and nursing mothers should discontinue breastfeeding while taking it. Administer this medication carefully to children and the elderly, as overdose may lead to symptoms such as headaches, nausea, and dizziness.
Hives, facial swelling, lymphangitis, angioedema, anaphylactic reactions, jaundice, liver failure, hepatitis, cholestasis, skin and mucous membrane reaction syndrome (Stevens-Johnson syndrome), toxic epidermal necrolysis (Lyell syndrome), acute generalized exanthematous pustulosis, erythema multiforme, toxic skin rashes, exfoliative dermatitis, bullous dermatitis, rhabdomyolysis, hypotension, respiratory distress, chest tightness, breathing difficulties, hematological disorders (neutropenia, pancytopenia, agranulocytosis,
Not everyone experiences these, and they can vary from person to person.
This medicine should be stored in a well-closed container, away from air, and at a temperature between 1 and 30 degrees Celsius. Storing in this manner will keep the ingredients stable and safe for use.
White to whitish round tablets
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowTerbinafine Hydrochloride 140.625mg
Tablet · Prescription medication
McNulty Pharmaceutical Co., Ltd.
Terbinafine Hydrochloride 10mg
Cream · OTC medication
GP Therapeutics Korea Co., Ltd.
Terbinafine Hydrochloride 10mg
Cream · OTC medication
Korea Hutex Pharmaceutical Co., Ltd.
Terbinafine Hydrochloride 10mg
Cream · OTC medication
Anguk Pharmaceutical Co., Ltd.
Terbinafine Hydrochloride 10mg
Cream · OTC medication
Medica Korea Co., Ltd.
Terbinafine Hydrochloride 10mg
Cream · OTC medication
Gyeongnam Pharmaceutical Co., Ltd.
Terbinafine Hydrochloride 10mg
Cream · OTC medication
Daehwa Pharmaceutical Co., Ltd.
Terbinafine Hydrochloride 10mg
Cream · OTC medication
Korea Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.